These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. A population-based analysis of germline BAP1 mutations in melanoma. O'Shea SJ; Robles-Espinoza CD; McLellan L; Harrigan J; Jacq X; Hewinson J; Iyer V; Merchant W; Elliott F; Harland M; Bishop DT; Newton-Bishop JA; Adams DJ Hum Mol Genet; 2017 Feb; 26(4):717-728. PubMed ID: 28062663 [TBL] [Abstract][Full Text] [Related]
32. Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases. Zhang JX; Fu L; de Voer RM; Hahn MM; Jin P; Lv CX; Verwiel ET; Ligtenberg MJ; Hoogerbrugge N; Kuiper RP; Sheng JQ; Geurts van Kessel A World J Gastroenterol; 2015 Apr; 21(14):4136-49. PubMed ID: 25892863 [TBL] [Abstract][Full Text] [Related]
33. Whole-exome sequencing reveals novel genetic variants associated with diverse phenotypes of melanoma cells. Hartman ML; Sztiller-Sikorska M; Czyz M Mol Carcinog; 2019 Apr; 58(4):588-602. PubMed ID: 30556601 [TBL] [Abstract][Full Text] [Related]
34. Melanoma-prone families: new evidence of distinctive clinical and histological features of melanomas in CDKN2A mutation carriers. Gironi LC; Colombo E; Pasini B; Giorgione R; Farinelli P; Zottarelli F; Esposto E; Zavattaro E; Allara E; Ogliara P; Betti M; Dianzani I; Savoia P Arch Dermatol Res; 2018 Dec; 310(10):769-784. PubMed ID: 30218143 [TBL] [Abstract][Full Text] [Related]
35. Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants. Rayner JE; Duffy DL; Smit DJ; Jagirdar K; Lee KJ; De'Ambrosis B; Smithers BM; McMeniman EK; McInerney-Leo AM; Schaider H; Stark MS; Soyer HP; Sturm RA PLoS One; 2020; 15(9):e0238529. PubMed ID: 32966289 [TBL] [Abstract][Full Text] [Related]
36. Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families. Potjer TP; Bollen S; Grimbergen AJEM; van Doorn R; Gruis NA; van Asperen CJ; Hes FJ; van der Stoep N; Int J Cancer; 2019 May; 144(10):2453-2464. PubMed ID: 30414346 [TBL] [Abstract][Full Text] [Related]
37. Founder Mutations for Early Onset Melanoma as Revealed by Whole Exome Sequencing Suggests That This is Not Associated with the Increasing Incidence of Melanoma in Poland. Dębniak T; Scott RJ; Lea RA; Górski B; Masojć B; Cybulski C; Kram A; Maleszka R; Gromowski T; Paszkowska-Szczur K; Kashyap A; Lener MR; Malińska K; Rogoża E; Murawa D; Rudnicka H; Deptuła J; Lubiński J Cancer Res Treat; 2019 Jan; 51(1):337-344. PubMed ID: 29764119 [TBL] [Abstract][Full Text] [Related]
38. Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets. Lyu J; Song Z; Chen J; Shepard MJ; Song H; Ren G; Li Z; Guo W; Zhuang Z; Shi Y J Pathol; 2018 Mar; 244(3):358-366. PubMed ID: 29230811 [TBL] [Abstract][Full Text] [Related]
39. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families. Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698 [TBL] [Abstract][Full Text] [Related]